Insider Buying: Kewaunee Scientific Co. (NASDAQ:KEQU) Director Buys 1,000 Shares of Stock

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) Director Keith M. Gehl bought 1,000 shares of the business's stock in a transaction on Friday, April 4th. The shares were acquired at an average price of $35.00 per share, with a total value of $35,000.00. Following the completion of the purchase, the director now directly owns 18,500 shares of the company's stock, valued at approximately $647,500. The trade was a 5.71 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.

Kewaunee Scientific Price Performance

NASDAQ:KEQU traded down $1.31 on Friday, hitting $33.24. The company had a trading volume of 17,788 shares, compared to its average volume of 23,628. Kewaunee Scientific Co. has a 52 week low of $30.82 and a 52 week high of $71.33. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $94.90 million, a price-to-earnings ratio of 5.27 and a beta of 0.59. The firm has a 50 day moving average of $49.68 and a two-hundred day moving average of $47.36.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. The company had revenue of $67.17 million during the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded Kewaunee Scientific from a "buy" rating to a "hold" rating in a research note on Friday, March 14th.

Institutional Trading of Kewaunee Scientific

A number of hedge funds have recently made changes to their positions in KEQU. State Street Corp bought a new position in Kewaunee Scientific in the 3rd quarter valued at approximately $266,000. Barclays PLC acquired a new position in Kewaunee Scientific in the 3rd quarter valued at approximately $121,000. Geode Capital Management LLC raised its stake in shares of Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock valued at $792,000 after acquiring an additional 1,941 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock worth $30,000 after purchasing an additional 900 shares during the period. Finally, Ritholtz Wealth Management grew its stake in shares of Kewaunee Scientific by 15.6% in the fourth quarter. Ritholtz Wealth Management now owns 12,619 shares of the technology company's stock worth $781,000 after purchasing an additional 1,706 shares during the last quarter. 32.69% of the stock is owned by institutional investors and hedge funds.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.